We are live on ! Find out more
CSBR icon

Champions Oncology
CSBR

37 hedge funds and large institutions have $46.7M invested in Champions Oncology in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1.44% less ownership

Funds ownership: 52.8% → 51.36% (-1.4%)

3% less funds holding

Funds holding: 38 → 37 (-1)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

22% less capital invested

Capital invested by funds: $60.1M → $46.7M (-$13.3M)

Holders
37
Holders Change
-1
Holders Change %
-2.63%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
9
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$686K
2
EIM
Essex Investment Management
Massachusetts
+$511K
3
WCM
Wedge Capital Management
North Carolina
+$311K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$196K
5
BlackRock
BlackRock
New York
+$129K

Top Sellers

Rank Fund Capital Flow
1
SSA
Schonfeld Strategic Advisors
New York
-$1.24M
2
GIP
Granite Investment Partners
California
-$790K
3
EI
EAM Investors
California
-$459K
4
PCM
Perkins Capital Management
Minnesota
-$282K
5
DCM
Driehaus Capital Management
Illinois
-$194K
Name Holding Trade Value Shares
Change 		Change in
Stake
Arrowstreet Capital
26
Arrowstreet Capital
Massachusetts
$179K – – –
PAM
27
Panagora Asset Management
Massachusetts
$32K -$2.89K -329 -8%
PCM
28
Prelude Capital Management
New York
$27K -$43.8K -4,994 -59%
Morgan Stanley
29
Morgan Stanley
New York
$27K – – –
VIMU
30
Veritas Investment Management (UK)
United Kingdom
$16K – – –
TRCT
31
Tower Research Capital (TRC)
New York
$12K +$9.66K +1,101 +267%
FIA
32
FNY Investment Advisers
New York
$5K +$5.89K +672 New
APC
33
Aspire Private Capital
North Carolina
$3K -$2.13K -243 -37%
UBS Group
34
UBS Group
Switzerland
$2K +$1.97K +225 New
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$1K +$877 +100 New
Bank of America
36
Bank of America
North Carolina
$1K +$1.13K +129 New
SSA
37
Schonfeld Strategic Advisors
New York
– -$1.24M -126,900 Closed
EI
38
EAM Investors
California
– -$459K -46,892 Closed
DCM
39
Driehaus Capital Management
Illinois
– -$194K -19,797 Closed
Millennium Management
40
Millennium Management
New York
– -$146K -14,869 Closed
Bank of Montreal
41
Bank of Montreal
Ontario, Canada
– -$140K -14,288 Closed
Marshall Wace
42
Marshall Wace
United Kingdom
– -$99K -10,066 Closed
LTFS
43
Ladenburg Thalmann Financial Services
Florida
– +$140 +16 New
1
2

CSBR Hedge Fund Activity: Q2 2019 in Review

37 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q2 2019, worth a combined $46.7M — down 22% from $60.1M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CSBR and 6 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 9 added.

The largest buyer was Wells Fargo, adding an estimated $686K. The largest seller was Schonfeld Strategic Advisors, exiting entirely with an estimated $1.24M sold.

  • 37 institutional investors held Champions Oncology (CSBR) as of Q2 2019, down from 38 in Q1 2019.
  • Funds reported $46.7M of Champions Oncology stock for Q2 2019, down 22% quarter-over-quarter.
  • 6 funds opened new Champions Oncology positions in Q2 2019 and 7 closed out, a net change of -1 holder.
  • The largest Champions Oncology buyer in Q2 2019 was Wells Fargo, an estimated $686K added.
  • The largest Champions Oncology seller in Q2 2019 was Schonfeld Strategic Advisors, an estimated $1.24M sold.

Based on aggregated 13F filings for Q2 2019.